TY  - JOUR
AU  - Fazzino, Tera L
AU  - Fleming, Kimberly
AU  - Befort, Christie
PY  - 2016
DA  - 2016/11/09
TI  - Alcohol Intake Among Breast Cancer Survivors: Change in Alcohol Use During a Weight Management Intervention
JO  - JMIR Cancer
SP  - e15
VL  - 2
IS  - 2
KW  - alcohol drinking
KW  - breast cancer
KW  - weight loss
KW  - weight reduction programs
KW  - obesity
AB  - Background: Daily alcohol intake in quantities as small as half a drink/day significantly increases the risk of breast cancer recurrence for postmenopausal survivors. Interventions designed to modify alcohol use among survivors have not been studied; however, lifestyle interventions that target change in dietary intake may affect alcohol intake. Objective: To evaluate change in alcohol use during a weight loss intervention for obese, rural-dwelling breast cancer survivors. Methods: Data were derived from an 18-month trial that included a 6-month weight loss intervention delivered via group conference calls, followed by a 12-month randomized weight loss maintenance phase in which participants received continued group calls or mailed newsletters. Participants who reported regular alcohol use at baseline (N=37) were included in this study. Results: Mean daily alcohol intake significantly decreased from baseline to 6 months during the weight loss intervention (19.6-2.3 g; P=.001). Mean alcohol intake did not significantly increase (b=0.99, P=.12) during the weight loss maintenance phase (months 6-18) and did not depend on randomization group (b=0.32, P=.799). Conclusions: Findings provide preliminary evidence that a weight loss intervention may address obesity and alcohol use risk factors for cancer recurrence. Minimal mail-based contact post weight loss can maintain alcohol use reductions through 18 months, suggesting durability in these effects. These results highlight a possibility that lifestyle interventions for survivors may modify health behaviors that are not the main foci of an intervention but that coincide with intervention goals. Trial Registration: Clinicaltrials.gov NCT01441011; https://clinicaltrials.gov/ct2/show/NCT01441011 (Archived by WebCite at http://www.webcitation.org/6lsJ9dMa9) 
SN  - 2369-1999
UR  - http://cancer.jmir.org/2016/2/e15/
UR  - https://doi.org/10.2196/cancer.6295
UR  - http://www.ncbi.nlm.nih.gov/pubmed/28410181
DO  - 10.2196/cancer.6295
ID  - info:doi/10.2196/cancer.6295
ER  -